AUPHAurinia Pharmaceuticals Inc.

$16.54

Who owns AUPH

255 institutions reported holding AUPH for 2026Q1, together 54% of the company, more than the 251 a quarter earlier.

255

Institutions reporting a position · as of 2026Q1 · up from 251 the quarter before

Shares held by institutions
73.9M

Shares held by institutions · 54% of the company · long US equity positions only, as reported on Form 13F

Reported value
$1.09B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
22%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
47
New positions
34
Positions exited
36
Added to
99
Reduced
61
Top 10 holdersof the company
30%
Institutional ownership by quarter, 2014Q3 to 2026Q1
QuarterFilersSharesReported value
2026Q125573.9M$1.09B
2025Q425172.6M$1.15B
2025Q323865.9M$729M
2025Q221758.7M$497M
2025Q121362.7M$504M
2024Q419858.5M$525M
2024Q318058.5M$429M
2024Q216956.0M$320M
2024Q117755.8M$281M
2023Q419054.0M$485M
2023Q319750.9M$395M
2023Q219950.3M$487M
2023Q118450.4M$553M
2022Q419151.5M$223M
2022Q318755.9M$420M
2022Q219650.7M$510M
Largest reported holders, 2026Q1
HolderShares% of companyValue
TANG CAPITAL MANAGEMENT LLC12.2M8.9%$181M
BlackRock Inc.7.8M5.7%$116M
NEA Management Company, LLC4.0M2.9%$59M
TWO SIGMA INVESTMENTS, LP3.4M2.5%$51M
ARROWSTREET CAPITAL LIMITED PARTNERSHIP3.3M2.4%$49M
STATE STREET CORP2.5M1.8%$37M
MORGAN STANLEY2.2M1.6%$33M
Marshall Wace LLP1.9M1.4%$28M
RENAISSANCE TECHNOLOGIES LLC1.7M1.2%$25M
D. E. Shaw & Co., INC.1.6M1.1%$23M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…